NDRG3 and hepatocellular carcinoma: Moreover, recent studies have indicated that human miR-122 significantly facilitated hepatitis C virus (HCV) replication, whereas miR-122 by targeting NDRG3 inhibits hepatitis B virus (HBV) replication in human hepatocellular carcinoma (HCC) and HCC-derived cell lines [23,24].